VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
ACGLArch Capital Group Ltd.
$97.54$34.1B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksACGLFinancials

Arch Capital Group Ltd. (ACGL) Financials

30Y historyFree accessUpdated daily

Revenue growth has decelerated from a 36.0% peak in 2024Q3 to a 5.0% contraction in 2026Q1, though underwriting discipline persists with a 73.7% combined ratio.

ACGL Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Revenue19.7B19.93B17.44B13.29B9.66B8.92B8.29B6.78B5.47B5.37B4.45B3.98B4.05B3.48B3.38B3.09B3.21B3.5B2.97B3.45B3.45B3.17B3.1B2.34B721.77M76.45M127.63M348.77M247.13M120.97M50.2M
Revenue Growth %8.51%14.27%31.19%37.66%8.21%7.62%22.27%23.88%1.96%20.61%11.93%-1.86%16.52%2.91%9.37%-3.77%-8.29%18.03%-14.07%-0.01%9%2.04%32.44%224.72%844.06%-40.1%-63.4%41.13%104.29%140.98%904%
Medical Costs & Claims11.26B12.52B10.99B8.56B6.77B5.89B5.69B3.97B3.7B3.74B2.85B2.71B2.58B2.24B2.37B2.19B1.96B2.15B2.74B2.12B2.33B2.58B2.44B1.84B543.5M24.26M103.02M386.34M243.13M104.91M34.28M
Medical Cost Ratio %57.17%62.84%63.03%64.37%70.08%65.98%68.68%58.6%67.5%69.71%64.09%68.23%63.57%64.5%70.12%70.88%61%61.35%92.19%61.54%67.61%81.51%78.62%78.4%75.3%31.73%80.71%110.77%98.38%86.72%68.28%
Gross Profit8.44B7.41B6.45B4.74B2.89B3.04B2.6B2.81B1.78B1.63B1.6B1.26B1.48B1.23B1.01B899.79M1.25B1.35B231.76M1.33B1.12B585.66M663.53M506.18M178.27M52.19M24.61M-37.57M4.01M16.07M15.92M
Gross Margin %42.83%37.16%36.97%35.63%29.92%34.02%31.32%41.4%32.5%30.29%35.91%31.77%36.43%35.5%29.88%29.12%39%38.65%7.81%38.46%32.39%18.49%21.38%21.6%24.7%68.27%19.29%-10.77%1.62%13.28%31.72%
Gross Profit Growth %-14.88%36.13%63.93%-4.84%16.89%-7.48%57.79%9.39%1.75%26.51%-14.41%19.57%22.27%12.22%-28.17%-7.45%483.97%-82.55%18.74%90.93%-11.74%31.09%183.94%241.56%112.04%165.51%-1037.45%-75.05%0.9%218.42%
Operating Expenses2.99B2.43B1.97B1.63B1.52B1.3B1.18B1.08B982.96M1.01B791.43M721.83M651.86M527.79M493.88M463.81M463.59M455.74M-72.75M454.2M378.32M300.23M320.4M199.68M123.73M28.05M24.11M14.66M-454K14.17M-24.08M
OpEx / Revenue %15.18%12.18%11.31%12.25%15.71%14.56%14.27%15.99%17.96%18.84%17.78%18.15%16.08%15.17%14.61%15.01%14.44%13.01%-2.45%13.16%10.96%9.48%10.32%8.52%17.14%36.69%18.89%4.2%-0.18%11.72%-47.97%
Depreciation & Amortization174M193M235M95M106M82M69.03M82.1M105.67M125.78M19.34M22.93M0000000000000000000
Combined Ratio %72.35%75.02%74.35%76.63%85.79%80.54%82.95%74.59%85.46%88.55%81.87%86.38%79.66%79.68%84.74%85.89%75.43%74.36%89.74%74.7%78.57%90.99%88.95%86.92%92.44%68.42%99.61%114.98%98.19%98.44%20.32%
Operating Income5.45B4.98B4.47B3.11B1.37B1.74B1.41B1.72B796.13M614.99M807.08M541.74M824.36M706.8M515.88M435.98M789M897.65M304.5M873.54M739.89M285.44M343.13M306.5M54.54M24.14M503K-52.23M4.46M1.89M40M
Operating Margin %27.65%24.98%25.65%23.37%14.21%19.46%17.05%25.41%14.54%11.45%18.13%13.62%20.34%20.32%15.26%14.11%24.57%25.64%10.26%25.3%21.43%9.01%11.05%13.08%7.56%31.58%0.39%-14.98%1.81%1.56%79.68%
Operating Income Growth %-11.29%44%126.46%-21.01%22.84%-17.94%116.45%29.45%-23.8%48.98%-34.28%16.63%37.01%18.33%-44.74%-12.1%194.79%-65.14%18.06%159.22%-16.81%11.95%461.97%125.89%4700%100.96%-1270.57%135.71%-95.27%-
EBITDA5.62B5.17B4.71B3.2B1.48B1.82B1.48B1.81B901.8M740.77M826.42M564.66M889.88M769.57M617.91M458.06M880.41M922.09M328.34M895.64M761.98M307.94M361.1M307.91M54.54M24.14M503K-52.23M4.46M1.89M40M
EBITDA Margin %28.53%25.95%27%24.09%15.3%20.38%17.89%26.62%16.47%13.8%18.56%14.2%21.96%22.13%18.28%14.82%27.41%26.33%11.07%25.94%22.07%9.72%11.63%13.14%7.56%31.58%0.39%-14.98%1.81%1.56%79.68%
Interest Expense150M148M141M133M131M139M143.46M120.87M120.48M117.43M66.25M45.87M45.63M27.06M28.52M31.69M30.01M24.44M23.84M22.09M22.09M22.5M17.97M1.41M0000000
Non-Operating Income-182M-180M-141M-411M-246M-505M-290.15M-244.54M-166.13M-259.72M-114.73M-71.33M-65.52M-62.76M-102.03M-22.09M-91.41M-24.44M-23.84M-22.09M-22.09M-22.5M-17.97M-1.41M0000000
Pretax Income5.61B5.16B4.67B3.57B1.56B2.37B1.58B1.85B841.77M757.28M855.55M567.19M844.25M742.5M589.39M426.37M850.4M897.65M304.5M873.54M739.89M285.44M343.13M306.5M54.54M24.14M503K-52.23M4.46M1.89M4.4M
Pretax Margin %28.47%25.89%26.8%26.85%16.17%26.52%19.03%27.27%15.38%14.1%19.22%14.26%20.83%21.35%17.44%13.8%26.48%25.64%10.26%25.3%21.43%9.01%11.05%13.08%7.56%31.58%0.39%-14.98%1.81%1.56%8.76%
Income Tax737M760M362M-873M80M128M111.84M155.81M113.95M127.57M31.37M40.61M22.99M32.77M-4.01M-9.79M7.73M20.71M13.54M15.6M26.68M28.95M26.23M26.73M-556K2.13M8.52M-19.56M235K-338K300K
Effective Tax Rate %13.14%14.73%7.74%-24.46%5.12%5.41%7.09%8.43%13.54%16.85%3.67%7.16%2.72%4.41%-0.68%-2.3%0.91%2.31%4.45%1.79%3.61%10.14%7.64%8.72%-1.02%8.81%1692.84%37.44%5.27%-17.86%6.82%
Net Income4.87B4.4B4.31B4.44B1.48B2.16B1.41B1.64B757.97M619.28M692.74M537.74M834.36M709.73M593.4M436.16M842.67M876.95M290.97M857.94M713.21M256.49M316.9M280.59M58.98M22.02M-8.01M-32.44M3.09M2.04M4.1M
Net Margin %24.73%22.07%24.72%33.42%15.28%24.17%16.95%24.13%13.85%11.53%15.56%13.52%20.59%20.41%17.56%14.11%26.24%25.04%9.81%24.85%20.66%8.1%10.21%11.97%8.17%28.8%-6.28%-9.3%1.25%1.69%8.17%
Net Income Growth %29.37%2.02%-2.95%201.02%-31.57%53.47%-14.1%115.88%22.4%-10.6%28.82%-35.55%17.56%19.6%36.05%-48.24%-3.91%201.39%-66.09%20.29%178.07%-19.06%12.94%375.72%167.91%374.79%75.3%-1149.37%51.59%-50.27%310%
EPS (Diluted)13.5411.6211.1911.623.805.233.323.871.841.361.781.362.011.691.340.991.731.530.451.251.010.380.490.460.110.14-0.07-0.210.020.010.03
EPS Growth %33.54%3.84%-3.7%205.79%-27.34%57.53%-14.21%110.33%35.29%-23.6%30.88%-32.34%18.93%26.12%35.35%-42.77%13.07%240%-64%23.76%165.79%-22.45%6.52%318.18%-21.43%290.22%64.95%-1211.11%42.11%-50.19%-
EPS (Basic)-11.8411.4711.943.905.343.383.971.871.401.831.412.071.751.381.031.811.590.471.301.050.811.121.190.330.19-0.07-0.210.020.010.03
Diluted Shares Outstanding359.7M376.1M381.8M378.8M377.61M400.35M410.26M411.61M412.91M417.79M374.15M378.12M404.77M407.33M414.78M414.87M472.7M557.34M583.1M663.86M686.22M672.39M652.67M610M536.96M153.02M118.78M153.78M159.46M153.77M153.75M

Key Metrics

Growth RegimeMixed
ProfitabilityStrong
Balance SheetHealthy
Cash FlowRobust
Top Statement Risk

Social inflation and litigation

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Premium Growth Faces Cyclical Headwinds

As reported in financial statements, Arch Capital's revenue growth trajectory has shifted from a peak of 36.0% in 2024Q3 to a contraction of 5.0% in 2026Q1, suggesting that the company is navigating a transition from a period of aggressive expansion to a more disciplined underwriting environment.

The recent deceleration in top-line growth appears to reflect a strategic pivot away from underpriced risks as the hard market cycle matures. Investors should monitor whether this contraction is a temporary tactical retreat or a sign of broader market saturation in the company's core reinsurance and insurance segments.

Underwriting Discipline Drives Margin Resilience

Based on reported figures, Arch Capital maintained a combined ratio of 73.7% in 2026Q1, demonstrating that the firm continues to generate significant underwriting profit despite the volatility observed in the loss ratio, which fluctuated between 47.9% and 73.0% over the last ten quarters.

The ability to keep the combined ratio well below the 100% threshold suggests that the company's risk selection remains highly effective. This margin profile appears to be supported by the unique contribution of the mortgage insurance segment, which provides a structural buffer against the inherent volatility of property and casualty lines.

Strategic Pivot Amidst Market Normalization

According to recent SEC filings, the 2025Q1 period marked a significant inflection point where the loss ratio spiked to 73.0%, coinciding with a sharp 49.3% decline in EPS, which highlights the company's sensitivity to sudden shifts in claims frequency and severity within its diversified portfolio.

This period warrants further investigation as it may indicate the impact of social inflation or unexpected catastrophe activity on long-tail casualty reserves. The subsequent recovery in profitability suggests that management's reactive adjustments to pricing and risk appetite were effective in stabilizing the bottom line.

Reserve Adequacy and Litigation Tailwinds

While Arch Capital reports robust underwriting margins, the reliance on prior-year reserve development to smooth earnings, as noted in historical filings, suggests that investors should remain cautious regarding the potential for future adverse development in long-tail casualty lines currently impacted by rising social inflation.

The company's historical earnings stability may be partially masked by the timing of reserve releases, which could obscure the true underlying profitability of the current accident year. If litigation trends continue to accelerate, the current reserve levels may appear less conservative than they have historically been, potentially necessitating future strengthening.

ACGL — Frequently Asked Questions

Quick answers to the most common questions about buying ACGL stock.

What was Arch Capital Group Ltd.'s (ACGL) revenue in 2025?

For fiscal year 2025, Arch Capital Group Ltd. (ACGL) reported total revenue of $19.93B. This represents a 39599.2% increase compared to $50.2M in 1996.

Is Arch Capital Group Ltd. (ACGL) profitable?

Arch Capital Group Ltd. (ACGL) is profitable, generating $4.40B in net income for the fiscal year ending 2025 with a net profit margin of 22.1%.

What is Arch Capital Group Ltd.'s operating profit margin?

Arch Capital Group Ltd. (ACGL) reported an operating income of $4.98B, resulting in an operating profit margin of 25.0%. This margin reflects the operational efficiency of the business before interest and taxes.

What is Arch Capital Group Ltd.'s gross profit and gross margin?

Arch Capital Group Ltd. (ACGL) generated $7.41B in gross profit for the year, representing a gross profit margin of 37.2%. This demonstrates the company's core pricing power and production efficiency.